• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Meissa raises $30M to take RSV vaccine into the clinic

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 26, 2019 at 11:02: AM
via Meissa Vaccines has raised $30 million to advance a pipeline of vaccines to prevent viral respiratory infections. The series A equips Meissa to run phase 1 and 2 trials of a respiratory syncytial virus vaccine.

article source
 

<



Similar threads

cafead
Meissa reports positive data from trial of pediatric RSV vaccine
Replies
0
Views
108
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Meissa Vaccines’ leg up in the Covid-19 vaccines chase goes through the nose
Replies
0
Views
157
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Startup from George Church’s lab raises $75M to develop ‘supercell’ medicines
Replies
0
Views
1
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
F2G raises $100M to bring antifungal drug back to FDA
Replies
0
Views
6
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Lilly-backed Superluminal raises $120M series A to bring membrane receptor drugs into the clinic
Replies
0
Views
10
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote